Search Results - "Beutner, K R"

Refine Results
  1. 1

    Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults by BEUTNER, K. R, FRIEDMAN, D. J, FORSZPANIAK, C, ANDERSEN, P. L, WOOD, M. J

    Published in Antimicrobial Agents and Chemotherapy (01-07-1995)
    “…Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon…”
    Get full text
    Journal Article
  2. 2

    Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream by Beutner, Karl R., Geisse, John K., Helman, Donita, Fox, Terry L., Ginkel d, Angela, Owens, Mary L.

    “…Background: Basal cell carcinoma (BCC) responds to interferon therapy. Imiquimod is a cytokine and interferon inducer. Objective: This randomized, double-blind…”
    Get full text
    Journal Article
  3. 3

    Treatment of genital warts with an immune-response modifier (imiquimod) by Beutner, Karl R., Spruance, Spotswood L., Hougham, Andrina J., Fox, Terry L., Owens, Mary L., Douglas, John M.

    “…Background: Genital warts are a common sexually transmitted disease caused by human papillomavirus. Imiquimod is a novel immune-response modifier capable of…”
    Get full text
    Journal Article
  4. 4

    Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy by Beutner, Karl R.

    Published in Antiviral Research (01-12-1995)
    “…Oral administration of the prodrug valacyclovir results in enhanced bioavailability and significantly greater plasma concentrations of acyclovir than can be…”
    Get full text
    Book Review Journal Article
  5. 5

    Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts by BEUTNER, K. R, TYRING, S. K, TROFATTER, K. F, DOUGLAS, J. M, SPRUANCE, S, OWENS, M. L, FOX, T. L, HOUGHAM, A. J, SCHMITT, K. A

    Published in Antimicrobial Agents and Chemotherapy (01-04-1998)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  6. 6

    Polyphenon E®: a new treatment for external anogenital warts by Tatti, S., Stockfleth, E., Beutner, K.R., Tawfik, H., Elsasser, U., Weyrauch, P., Mescheder, A.

    Published in British journal of dermatology (1951) (01-01-2010)
    “…Summary Background  External genital warts (EGWs, condylomata acuminata) are a common, highly contagious disease caused by human papillomavirus (HPV),…”
    Get full text
    Journal Article
  7. 7

    Significant variation between SNP-based HLA imputations in diverse populations: the last mile is the hardest by Pappas, D J, Lizee, A, Paunic, V, Beutner, K R, Motyer, A, Vukcevic, D, Leslie, S, Biesiada, J, Meller, J, Taylor, K D, Zheng, X, Zhao, L P, Gourraud, P-A, Hollenbach, J A, Mack, S J, Maiers, M

    Published in The pharmacogenomics journal (22-05-2018)
    “…Four single nucleotide polymorphism (SNP)-based human leukocyte antigen (HLA) imputation methods (e-HLA, HIBAG, HLA*IMP:02 and MAGPrediction) were trained…”
    Get full text
    Journal Article
  8. 8

    External Genital Warts: Report of the American Medical Association Consensus Conference by Beutner, Karl R., Reitano, Michael V., Richwald, Gary A., Wiley, Dorothy J.

    Published in Clinical infectious diseases (01-10-1998)
    “…A consensus process was undertaken to describe and evaluate current information and practice regarding the diagnosis, treatment, and evaluation of patients…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Genital Warts and Their Treatment by Beutner, Karl R., Wiley, Dorothy J., Douglas, John M., Tyring, Stephen K., Fife, Kenneth, Trofatter, Kenneth, Stone, Katherine M.

    Published in Clinical infectious diseases (01-01-1999)
    “…Genital warts are manifestations of a common viral sexually transmitted disease (STD) that are often diagnosed and treated with a variety of clinical…”
    Get full text
    Journal Article Conference Proceeding
  10. 10
  11. 11

    Nongenital human papillomavirus infections by Beutner, K R

    Published in Clinics in laboratory medicine (01-06-2000)
    “…Although genital HPV types produce a broad spectrum of disease, the nongenital types are a bit more predictive. Particularly in the immunocompromised patient,…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14

    Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis by Reyes, Blas A., Beutner, Karl R., Cullen, Stanley I., Rosen, Theodore, Shupack, Jerome L., Weinstein, Mark B.

    Published in International journal of dermatology (01-06-1998)
    “…A multi‐center, randomized, double‐blind, placebo‐controlled trial was performed to evaluate the effectiveness of butenafine, a fungicidal benzylamine…”
    Get full text
    Journal Article
  15. 15

    Epidemiology of human papillomavirus infections by Beutner, K R, Becker, T M, Stone, K M

    Published in Dermatologic clinics (01-04-1991)
    “…Human papillomavirus infection represents the most common mucocutaneous viral infection, and 3% to 5% of all patients have clinically evident warts. Human…”
    Get more information
    Journal Article
  16. 16

    Patient-applied podofilox for treatment of genital warts by Beutner, K R, Conant, M A, Friedman-Kien, A E, Illeman, M, Artman, N N, Thisted, R A, King, D H

    Published in The Lancet (British edition) (15-04-1989)
    “…In a double-blind trial, 0.5% podofilox (podophyllotoxin) or placebo was applied by patients to their own genital warts in up to four treatment cycles. At some…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Topical podofilox for the treatment of condylomata acuminata in women by Baker, D A, Douglas, Jr, J M, Buntin, D M, Micha, J P, Beutner, K R, Patsner, B

    Published in Obstetrics and gynecology (New York. 1953) (01-10-1990)
    “…The purpose of this study was to determine the efficacy and safety of 0.5% podofilox solution (Condylox) for the treatment of genital warts in women…”
    Get more information
    Journal Article
  20. 20